Amneal Pharmaceuticals, Inc.: cash_and_restricted_cash

Value{"amount": 78345000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2024-09-30)
Statuscurrent
EntityAmneal Pharmaceuticals, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001723128-24-000042 · Open the official SEC filing →
Retrieved: 2026-08-19T17:37:46.930960+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001723128/cash-and-restricted-cash/2024-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/becfd3cd-32fc-4783-bc7a-29f136024bd6

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies